BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 38473896)

  • 21. Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.
    Pellino A; Riello E; Nappo F; Brignola S; Murgioni S; Djaballah SA; Lonardi S; Zagonel V; Rugge M; Loupakis F; Fassan M
    World J Gastroenterol; 2019 Oct; 25(38):5773-5788. PubMed ID: 31636471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic relevance of SOX9 stem cell factor in gastric cancer.
    Carrasco-Garcia E; Álvarez-Satta M; García-Puga M; Ribeiro ML; Arevalo S; Arauzo-Bravo M; Matheu A
    Expert Opin Ther Targets; 2019 Feb; 23(2):143-152. PubMed ID: 30572738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The journey of personalizing gastric cancer treatment.
    Yan L
    Chin J Cancer; 2016 Aug; 35(1):84. PubMed ID: 27581614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia.
    Wang D; Wang N; Li X; Chen X; Shen B; Zhu D; Zhu L; Xu Y; Yu Y; Shu Y
    Gastric Cancer; 2021 Jul; 24(4):823-834. PubMed ID: 33687617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global burden, risk factors, clinicopathological characteristics, molecular biomarkers and outcomes of microsatellite instability-high gastric cancer.
    Zhang Z; Huang J; Li Y; Yan H; Xie J; Wang J; Zhao B
    Aging (Albany NY); 2024 Jan; 16(1):948-963. PubMed ID: 38224334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectives.
    Abdi E; Latifi-Navid S; Zahri S; Yazdanbod A; Pourfarzi F
    Cancer Med; 2019 Oct; 8(13):6114-6126. PubMed ID: 31448582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging molecular classifications and therapeutic implications for gastric cancer.
    Chen T; Xu XY; Zhou PH
    Chin J Cancer; 2016 May; 35():49. PubMed ID: 27233623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LAMB1 Is Related to the T Stage and Indicates Poor Prognosis in Gastric Cancer.
    Ran T; Chen Z; Zhao L; Ran W; Fan J; Hong S; Yang Z
    Technol Cancer Res Treat; 2021; 20():15330338211004944. PubMed ID: 33784890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RHOJ Induces Epithelial-to-Mesenchymal Transition by IL-6/STAT3 to Promote Invasion and Metastasis in Gastric Cancer.
    Ma Z; Sun Q; Zhang C; Zheng Q; Liu Y; Xu H; He Y; Yao C; Chen J; Xia H
    Int J Biol Sci; 2023; 19(14):4411-4426. PubMed ID: 37781036
    [No Abstract]   [Full Text] [Related]  

  • 30. Development and Validation of an Easy-to-Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic Implications.
    Koh J; Lee KW; Nam SK; Seo AN; Kim JW; Kim JW; Park DJ; Kim HH; Kim WH; Lee HS
    Oncologist; 2019 Dec; 24(12):e1321-e1330. PubMed ID: 31371521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there still a place for conventional histopathology in the age of molecular medicine? Laurén classification, inflammatory infiltration and other current topics in gastric cancer diagnosis and prognosis.
    Díaz Del Arco C; Ortega Medina L; Estrada Muñoz L; García Gómez de Las Heras S; Fernández Aceñero MJ
    Histol Histopathol; 2021 Jun; 36(6):587-613. PubMed ID: 33565601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune-related gene signature predicts overall survival of gastric cancer patients with varying microsatellite instability status.
    Tian R; Hu J; Ma X; Liang L; Guo S
    Aging (Albany NY); 2020 Dec; 13(2):2418-2435. PubMed ID: 33316777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reproduction of molecular subtypes of gastric adenocarcinoma by transcriptome sequencing of archival tissue.
    Heo YJ; Park C; Yu D; Lee J; Kim KM
    Sci Rep; 2019 Jul; 9(1):9675. PubMed ID: 31273278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics.
    Wang H; Ding Y; Chen Y; Jiang J; Chen Y; Lu J; Kong M; Mo F; Huang Y; Zhao W; Fang P; Chen X; Teng X; Xu N; Lu Y; Yu X; Li Z; Zhang J; Wang H; Bao X; Zhou D; Chi Y; Zhou T; Zhou Z; Chen S; Teng L
    Gastric Cancer; 2021 Nov; 24(6):1227-1241. PubMed ID: 34095982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards standardization of lymph-node ratio classifications: Validation and comparison of different lymph node ratio classifications for predicting prognosis of patients with resected gastric cancer.
    Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
    Ann Diagn Pathol; 2021 Jun; 52():151738. PubMed ID: 33865185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening of Differentially Expressed Genes Based on the ACRG Molecular Subtypes of Gastric Cancer and the Significance and Mechanism of
    Zhang H; Zhen S; Ding P; Tan B; Wang H; Liu W; Tian Y; Zhao Q
    J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical classification of gastric cancer based on new molecular biomarkers: a potential predictor of survival.
    Díaz Del Arco C; Estrada Muñoz L; Molina Roldán E; Cerón Nieto MÁ; Ortega Medina L; García Gómez de Las Heras S; Fernández Aceñero MJ
    Virchows Arch; 2018 Dec; 473(6):687-695. PubMed ID: 30140949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer.
    Zhang L; Wang Y; Li Z; Lin D; Liu Y; Zhou L; Wang D; Wu A; Li Z
    Diagn Pathol; 2021 May; 16(1):38. PubMed ID: 33933102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer.
    Hu Q; Nonaka K; Wakiyama H; Miyashita Y; Fujimoto Y; Jogo T; Hokonohara K; Nakanishi R; Hisamatsu Y; Ando K; Kimura Y; Masuda T; Oki E; Mimori K; Oda Y; Mori M
    Cancer Med; 2021 May; 10(9):3129-3138. PubMed ID: 33769705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer.
    Song J; Wei R; Huo S; Gao J; Liu X
    Front Immunol; 2022; 13():920512. PubMed ID: 35769483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.